Kesimpta®(Ofatumumab): Targeted B-cell Therapy for Relapsing forms of Multiple Sclerosis
Dr. Juni Banerjee, PhD; Neucrad Health Desk, September 4, 2020 The Novartis drug Kesimpta® has been recently approved by FDA...
What is the Treatment of Multiple Sclerosis?
